(Q43263666)

English

Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist (English)

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

1 reference

based on heuristic

inferred from title

author name string

David J Behm

1

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Christopher L Herold

2

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Eliot H Ohlstein

3

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Steven D Knight

4

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Dashyant Dhanak

5

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Stephen A Douglas

6

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

137

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

4

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

449-458

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Effects of somatostatin and octreotide on portal-systemic collaterals in portal hypertensive rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Urotensin II evokes potent vasoconstriction in humans in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Cardiostimulant effects of urotensin-II in human heart in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Human urotensin II mediates vasoconstriction via an increase in inositol phosphates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

25 May 2018

Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

15 August 2018

Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

15 August 2018

Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

15 August 2018

Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

15 August 2018

Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573512

15 August 2018

Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin-II

1 reference

https://pubmed.ncbi.nlm.nih.gov/12359626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJP.0704887

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43263666&oldid=2050234519"